Researchers at Oxford announced today that a nasal spray version of the COVID-19 vaccine they’ve developed with AstraZeneca failed in early stages of clinical trials.

The drive to develop a nasal spray against COVID-19 infection suffered a setback Tuesday after AstraZeneca and Oxford University said a trial produced disappointing results.. Only a “minority of ...

AstraZeneca's COVID-19 nasal vaccine spray comes up a bust in small study By Kevin Dunleavy Oct 11, 2022 10:10am AstraZeneca Oxford University COVID-19 Bharat Biotech ...

S ince early in the pandemic, researchers have been working to develop a vaccine for SARS-CoV-2 that could be administered in the form of a nasal spray, as such a spray would be simpler to administer ...

A nasal spray version of AstraZeneca (AZN) and Oxford University's COVID-19 vaccine did not show the desired results in an early trial, according to the journal The Lancet,In the phase ...

Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans ...

One study of about 400 health-care workers suggests a nasal spray may reduce the incidence of COVID by up to 80%. IGM-6268 This is an engineered antibody that binds to SARS-CoV-2, blocking the ...

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against various respiratory infections, including COVID-19, influenza ...